about
Celiac disease and dermatologic manifestations: many skin clue to unfold gluten-sensitive enteropathyCellular dissection of psoriasis for transcriptome analyses and the post-GWAS eraImmunophenotype lymphocyte of peripheral blood in patients with psoriasis.Photo(chemo)therapy reduces circulating Th17 cells and restores circulating regulatory T cells in psoriasis.Genetic Epidemiology of PsoriasisPsoriasis is not an autoimmune disease?Inhibitory effect of Paeonia lactiflora Pallas extract (PE) on poly (I:C)-induced immune response of epidermal keratinocytesAntimicrobial peptide LL-37 along with peptidoglycan drive monocyte polarization toward CD14(high)CD16(+) subset and may play a crucial role in the pathogenesis of psoriasis guttataPsoriatic disease and tuberculosis nowadays.Ampelopsis japonica Makino Extract Inhibits the Inflammatory Reaction Induced by Pathogen-Associated Molecular Patterns in Epidermal KeratinocytesDysregulated expression of inflammation-related genes in psoriatic dermis mesenchymal stem cells.Antimicrobial Peptide LL37 and MAVS Signaling Drive Interferon-β Production by Epidermal Keratinocytes during Skin Injury.Neutrophil extracellular trap formation is increased in psoriasis and induces human β-defensin-2 production in epidermal keratinocytes.Hidradenitis suppurativa: the role of immune dysregulation.Postnatal Innate Immune Development: From Birth to Adulthood.Progress in understanding and utilizing TNF-α inhibition for the treatment of psoriatic arthritis.The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.Psoriasis, vitamin D and the importance of the cutaneous barrier's integrity: An update.Hepatitis C Infection in Egyptian Psoriatic Patients: Prevalence and Correlation with Severity of DiseaseDysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa.Two SNPs in the promoter region of Toll-like receptor 4 gene are not associated with smoking in Saudi Arabia.First-in-human studies of seletalisib, an orally bioavailable small-molecule PI3Kδ inhibitor for the treatment of immune and inflammatory diseases.Glucagon-like peptide-1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study.Altered mTORC1 signalling may contribute to macrophage dysregulation in hidradenitis suppurativa.Topical electrophilic nitro-fatty acids potentiate cutaneous inflammation.Psoriasis and inflammatory bowel disease: links and risks.
P2860
Q21285138-BD73C02C-5368-475F-BC00-133057427617Q33768338-AD9C4521-EDD8-49E2-AF90-3EF131F07DEAQ34557120-A69727AC-2757-46A8-989C-D5AB4E327C0DQ34568403-4EAB6C77-19C2-434D-B063-6DC97F3B5FE6Q34845927-0CEF8CC7-CEFD-4ABA-AE8E-ED5528CE15B4Q35369427-83416274-1A48-4845-84F8-8611FA29FFC6Q35854119-8569F86E-7E13-4259-BF78-05B45B92DA48Q35941306-92312D98-F380-40E6-A386-A501C1CE20F3Q35974892-88272EB7-EEC4-4B6E-84D5-605550173B65Q36946013-0A689C46-327D-4CBD-BD1E-409EBE0982ACQ37020090-4078FBFB-1568-471C-9FAA-178121994661Q37117847-47344999-C1EB-4894-81B2-CDE60332E17CQ37153882-A68C3276-4098-4CEC-940E-E3B3640DE188Q38222887-9F208C10-48CB-4D87-8C7A-3F9F6100591BQ38604836-716F19C0-4161-44A1-8ED0-06801F05C506Q38630548-2458373B-175D-43BF-BA42-832DD4EF8EB6Q38665824-CF4B4C20-B342-49E1-86FE-5E453938D844Q38772161-74E63088-E264-4A0F-929F-072C40264768Q39618857-F2F99851-55DF-46F1-8A95-7CFF492358AEQ41047761-60E2A85D-573A-43E5-B5A3-B69EDDBD4A40Q41785520-943614EF-0DEC-409B-8AE5-2D254BB59809Q41991078-58930229-4499-41AD-A6FA-AFAF92DF1BDBQ43466538-C8249B7D-779A-480A-914B-12265F9FF93FQ48321981-54E0F390-15B1-41E3-80D7-92E319B43E00Q50044277-97E7A1A4-D6BB-4F62-9C9A-8B2B61497868Q52859380-DF0E7FE3-A7B9-48B0-BDAD-EE778734993D
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Innate immunity in the pathogenesis of psoriasis.
@en
Innate immunity in the pathogenesis of psoriasis.
@nl
type
label
Innate immunity in the pathogenesis of psoriasis.
@en
Innate immunity in the pathogenesis of psoriasis.
@nl
prefLabel
Innate immunity in the pathogenesis of psoriasis.
@en
Innate immunity in the pathogenesis of psoriasis.
@nl
P2860
P1476
Innate immunity in the pathogenesis of psoriasis
@en
P2093
Brian Kirby
Cheryl M Sweeney
P2860
P2888
P304
P356
10.1007/S00403-011-1169-1
P50
P577
2011-08-24T00:00:00Z